.'Y7-N)^)V%DY;4/)2@<V8VC=*_3#
SYSTEM PROCESSING...
.'Y7-N)^)V%DY;4/)2@<V8VC=*_3#
SYSTEM PROCESSING...
Posted: 2025-04-24 04:54:08 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 04:56:20 UTC
Verified By
Rollup News
A Mendelian randomization study published in EHJPharmacotherapy investigates the potential of PDE5i, sGC stimulators, ERAs, and angiotensin receptor blockers to improve cardiovascular health.
Emerging antihypertensive therapies
Cardiovascular health
Mendelian randomization study
PDE5i
sGC stimulators
ERAs
Angiotensin receptor blockers